Manara - Qatar Research Repository
Browse
DOCUMENT
10.3389_fonc.2022.955358.pdf (9.79 MB)
DOCUMENT
supp_Data Sheet 1.PDF (1.06 MB)
1/0
2 files

Burden of thyroid cancer in North Africa and Middle East 1990–2019

Version 3 2024-04-22, 11:04
Version 2 2024-04-22, 10:35
Version 1 2024-04-22, 09:54
journal contribution
revised on 2024-04-22, 11:03 and posted on 2024-04-22, 11:04 authored by Seyed Aria Nejadghaderi, Sahar Saeedi Moghaddam, Sina Azadnajafabad, Negar Rezaei, Nazila Rezaei, Seyed Mohammad Tavangar, Hamidreza Jamshidi, Ali H. Mokdad, Mohsen Naghavi, Farshad Farzadfar, Bagher Larijani, GBD 2019 NAME Thyroid Cancer Collaborators, Hanadi Al Hamad, Mowafa Househ, Brijesh Sathian

Background

Thyroid cancer is the leading cause of mortality and morbidity among cancers of the endocrine system. We aimed to describe the trends of thyroid cancer burden in North Africa and Middle East for 1990–2019.

Methods

Data on burden of thyroid cancer in North Africa and Middle East from 1990 to 2019 were obtained from the Global Burden of Disease (GBD) Study 2019. Decomposition analysis was used to estimate the effects of population growth, aging, and change in incident numbers on overall change of thyroid cancer incidence. Also, we used the comparative risk assessment framework of GBD to determine the burden of thyroid cancer attributable to a high body mass index (BMI).

Results

In 2019, the age-standardized incidence rate (ASIR) and age-standardized mortality rate (ASMR) of thyroid cancer were 3.5 (2.9–4) and 0.5 (0.5–0.7) per 100,000, respectively. The highest age-standardized incidence, deaths, and disability-adjusted life year (DALY) rate were in Lebanon, Afghanistan, and United Arab Emirates, respectively. The ASIR of thyroid cancer in region was about 2.5 times higher among women, which had a positive association with increasing age. In 2019, the age-standardized deaths attributable to a high BMI was 16.7% of all deaths due to thyroid cancer. In 1990–2019, the overall change in thyroid cancer incident cases was a 396% increase which was mostly driven by the increase in disease-specific incidence rate (256.8%).

Conclusions

Women, the elderly above about 60 years old, and countries with a higher sociodemographic index showed higher incidence rates of thyroid cancer. Regarding our findings, it is recommended to establish preventive plans by modification in life style like weight reduction programs.

Erratum: Burden of thyroid cancer in North Africa and Middle East 1990–2019: Frontiers in Oncology https://dx.doi.org/10.3389/fonc.2023.1208646, published online 28 April 2023.

Other Information

Published in: Frontiers in Oncology
License: https://creativecommons.org/licenses/by/4.0/
See article on publisher's website: https://dx.doi.org/10.3389/fonc.2022.955358

Additional institutions affiliated with: WHO Collaborating Center for Healthy Ageing and Dementia - HMC

History

Language

  • English

Publisher

Frontiers

Publication Year

  • 2022

License statement

This Item is licensed under the Creative Commons Attribution 4.0 International License.

Institution affiliated with

  • Hamad Medical Corporation
  • Rumailah Hospital - HMC
  • Hamad Bin Khalifa University
  • College of Science and Engineering - HBKU

Methodology

Data on burden of thyroid cancer in North Africa and Middle East from 1990 to 2019 were obtained from the Global Burden of Disease (GBD) Study 2019. Decomposition analysis was used to estimate the effects of population growth, aging, and change in incident numbers on overall change of thyroid cancer incidence. Also, we used the comparative risk assessment framework of GBD to determine the burden of thyroid cancer attributable to a high body mass index (BMI).

Geographic coverage

North Africa and Middle East